View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/SAMHSA | RIN: 0930-AA22 | Publication ID: Spring 2016 |
Title: Increase Number of Patients to Which Drug Addiction Treatment Act (DATA)-Waived Physicians Can Prescribe Buprenorphine | |
Abstract:
Under the Drug Addiction Treatment Act of 2000, physicians must qualify and apply for a waiver to prescribe buprenorphine for opioid dependency. After one year, physicians can apply to SAMHSA to increase the buprenorphine treatment from 30 patients to 100 patients. The purpose of this rule is to expand access to medication-assisted treatment (MAT) by increasing the total number of patients a practitioner may treat with buprenorphine. The rule also includes requirements to ensure that patients receive the full array of services that compromise evidence-based MAT and minimize the risk that the medications provided for treatment are misused or diverted. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: Yes | Unfunded Mandates: No |
CFR Citation: 42 CFR 8 | |
Legal Authority: 21 U.S.C. 823(g)(2) |
Legal Deadline:
None |
||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Undetermined | Government Levels Affected: Federal, Local, State, Tribal |
Federalism: No | |
Included in the Regulatory Plan: Yes | |
RIN Data Printed in the FR: No | |
Agency Contact: Brian Altman Legislative Director Department of Health and Human Services Substance Abuse and Mental Health Services Administration 1 Choke Cherry Road, Rockville, MD 02857 Phone:240 276-2009 Email: brian.altman@samhsa.gov |